The ultimate goal for Concept in this area is that, globally, all women who want a first or second trimester abortion, will have safe, affordable and reliable products or methods available for termination of their pregnancy.
Concept is not, and will not be, involved in ethical or legal issues. It wants to use its expertise to get Medabon® ─ a quality-assured misoprostol-mifepristone product ─ registered and introduced in the public sector in as many countries as legally possible. This is being done in up to 20 lower and middle income countries through 2016, in continued partnership with, inter alia, IPPF, IPAS, PSI, WCG and MSI.
In 2009, Medical Service and Delivery Guidelines for Medabon® were released in 6 different languages: English, French, Spanish, Portuguese, Thai, and Vietnamese. These documents can be found on our Resources page.
Medabon® is already registered for the use in first trimester abortion. Presently Concept is leading a study for registration as a product for safe and effective abortion in the second trimester of pregnancy.
The work in the public sector has been funded by the Dutch Ministry of Foreign Affairs and by the Norwegian Government.